iBio, Inc. (IBIO) vs Serina Therapeutics, Inc. (SER)
- iBio, Inc. IBIO 0.77 −1.28%
- Serina Therapeutics, Inc. SER 1.77 −1.12%
iBio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. iBio, Inc. and Serina Therapeutics, Inc. are of similar size ($47.6M and $45.5M). iBio, Inc. grew revenue faster over the last twelve months: −66.6% against −94.2%. Across the 13 metrics below, iBio, Inc. leads on 11 and Serina Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | IBIO | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (65.70%) | (306.22%) | (56.36%) |
| Return on assets | (54.04%) | (136.00%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack